Biora Therapeutics, Inc. (BIORQ)
OTCMKTS · Delayed Price · Currency is USD
0.1150
-0.0200 (-14.81%)
Jul 30, 2025, 9:30 AM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Molecular Testing Products
4.00K
Log In
Log In
Log In
Log In
Upgrade
Molecular Testing Products Growth
-98.69%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
United States
4.00K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-98.69%
Log In
Log In
Log In
Log In
Upgrade